Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF EXECUTIVE OFFICER

CHIEF FINANCIAL OFFICER

INTERIM CEO & CFO

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a clinically validated molecular target. Its EO-3021 selectively delivers a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Elevation Oncology, Inc. has a license agreement with CSPC Megalith Biopharmaceutical Co., Ltd. to develop and commercialize EO-3021. The company was formerly known as 14ner Oncology, Inc. and changed its name to Elevation Oncology, Inc. in February 2020. The company was incorporated in 2019 and is based in New York, New York.

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a ran...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-16	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-16	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-02-15	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2023-12-16	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-12-16	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-09-16	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-09-16	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-09-01	Premium	gifted	Premium	Premium	Premium	-
2023-06-16	Premium	sold (taxes)	Premium	Premium	Premium	INTERIM CEO & CFO
2023-06-16	Premium	acquired	Premium	Premium	Premium	INTERIM CEO & CFO
2023-03-16	Premium	sold (taxes)	Premium	Premium	Premium	INTERIM CEO & CFO
2023-03-16	Premium	acquired	Premium	Premium	Premium	INTERIM CEO & CFO
2022-12-16	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-12-16	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-09-16	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-09-16	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-06-16	Premium	sold (taxes)	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-06-16	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-05-31	Premium	gifted	Premium	Premium	Premium	-
2022-05-25	Premium	sold	Premium	Premium	Premium	-
2021-06-29	Premium	bought	Premium	Premium	Premium	-
2021-06-29	Premium	acquired	Premium	Premium	Premium	-
2021-06-29	Premium	bought	Premium	Premium	Premium	-
2021-06-29	Premium	acquired	Premium	Premium	Premium	-

ELEV - Elevation Oncology, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for ELEV